Highest-Conviction Momentum Stock – Paresh Gordhandas Power Calls

⭐ High-Conviction Short-Term Pick

⭐⭐⭐⭐½ Windlas Biotech Ltd.

Windlas Biotech is a high-conviction momentum candidate for the next 4–6 weeks. The stock has positive MACD, RSI at 63.35, strong ADX/DMI and trades above all major moving averages. However, because it closed near the upper Bollinger Band after gaining 5.12%, investors should buy on declines or after a confirmed breakout—not chase immediately.

Windlas Biotech Investment Decision at a Glance

Windlas Biotech Trade Setup

Why Is Windlas Biotech a High-Conviction Pick?

Windlas Biotech closed at Rs. 964.95, gaining 5.12% in the latest session. The stock has risen 7.85% over one week and 9.59% over one month, confirming improving momentum without entering an excessively overheated RSI zone.

The technical structure is impressive. Windlas Biotech is trading above its 20-day, 34-day, 50-day, 89-day and 200-day moving averages. This broad moving-average alignment indicates that the price has established a solid base above its major trend indicators.

MACD stands at 24.52 against a signal reading of 17.13, while the positive histogram of 7.39 confirms accelerating momentum. ADX at 28.81 indicates a reasonably strong trend, and +DMI at 26.23 remains substantially above -DMI at 11.54, showing that buyers are firmly in control.

RSI at 63.35 falls within the preferred momentum range of 56–68. It indicates strong buying interest without the extreme overheating generally associated with RSI readings above 75–80.

Recent Performance

The weak one-year return and bearish 63-day trend indicate that the longer-term reversal is not yet fully established. This prevents Windlas Biotech from receiving a full five-star rating. Nevertheless, the bullish short- and medium-term trends support a 4–6 week momentum opportunity.

Trend Analysis

A sustained move above Rs. 989–Rs. 1,005 could strengthen the reversal and improve the long-term structure.

Price Structure

Windlas Biotech is currently:

• Trading above all important simple and exponential moving averages.
• Holding well above Parabolic SAR support at Rs. 829.44.
• Trading near the upper Bollinger Band of Rs. 965.32.
• Showing a positive MACD crossover with a rising histogram.
• Supported by strong DMI and ADX readings.
• Approaching the important breakout band of Rs. 980–Rs. 1,005.

Since the stock is near the upper Bollinger Band and Stochastic RSI is elevated, an immediate large gap-up should not be chased.

Bullish Scenario

A sustained move above Rs. 989 would confirm a fresh breakout. The first major target is Rs. 1,005, followed by Rs. 1,045.75.

If Windlas Biotech crosses Rs. 1,045 with healthy volume, the rally may extend towards Rs. 1,098–Rs. 1,131 over the next four to six weeks. The upper target represents approximately 17% upside from the latest close.

Bearish Scenario

Immediate support is placed at Rs. 949–Rs. 941, followed by Rs. 928. A close below Rs. 907 would weaken the momentum structure and invalidate the high-conviction setup.

Below Rs. 907, the stock could decline towards Rs. 875 and Rs. 822. Investors should not average the position if the prescribed stop-loss is breached.

Best Strategy for Windlas Biotech Investors

Accumulate on declines towards Rs. 928–950. Fresh buying after a rally should be considered only above Rs. 989 with strong volume. Book 40–50% profit near Rs. 1,045 and trail the remaining position towards Rs. 1,098–Rs. 1,131. After Target 1, raise the stop-loss to the purchase price.

Final Verdict

Windlas Biotech satisfies the principal momentum criteria: RSI within the preferred range, positive MACD, strong ADX/DMI, alignment above major averages and meaningful six-week upside. It is a Buy on declines, not a stock to chase after a large gap-up.

Paresh Gordhandas View

Windlas Biotech offers a strong short- and medium-term momentum setup, but the long-term reversal still needs confirmation. Accumulate at Rs. 928–950 or buy above Rs. 989, with targets of Rs. 1,045 and Rs. 1,098–Rs. 1,131. Maintain a strict stop-loss at Rs. 907.